Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (561-570 of 776) with videos related to

Pageof 78
Sort By:
The Journal of Biological Chemistry|May 2, 2006
Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activityAnthony R White, Tai Du, Katrina M Laughton, et al.
Journal of Alzheimer'S Disease : JAD|February 25, 2017
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older AdultsSimone Hollands, Yen Ying Lim, Simon M Laws, et al.
International Journal of Molecular Sciences|July 27, 2022
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's DiseaseYihan Li, Xin Huang, Christopher Fowler, et al.
Scientific Reports|December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNIRosita Shishegar, Timothy Cox, David Rolls, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Communications Medicine|February 27, 2025
Alzheimer's disease biological PET staging using plasma p217+tauAzadeh Feizpour, Vincent Doré, Natasha Krishnadas, et al.
Alzheimer'S Research & Therapy|April 11, 2015
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohortVeer B Gupta, Andrea C Wilson, Samantha Burnham, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's diseaseKunal Dhiman, Veer Bala Gupta, Victor L Villemagne, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2005
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathwayRoberto Cappai, Su-Ling Leck, Deborah J Tew, et al.
Nature|February 9, 2018
High performance plasma amyloid-β biomarkers for Alzheimer's diseaseAkinori Nakamura, Naoki Kaneko, Victor L Villemagne, et al.
Pageof 78

Showing results (561-570 of 776) with videos related to

Sort By:
Pageof 78
The Journal of Biological Chemistry|May 2, 2006
Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activityAnthony R White, Tai Du, Katrina M Laughton, et al.
Journal of Alzheimer'S Disease : JAD|February 25, 2017
APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older AdultsSimone Hollands, Yen Ying Lim, Simon M Laws, et al.
International Journal of Molecular Sciences|July 27, 2022
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's DiseaseYihan Li, Xin Huang, Christopher Fowler, et al.
Scientific Reports|December 11, 2021
Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNIRosita Shishegar, Timothy Cox, David Rolls, et al.
Neurology|August 19, 2016
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-upSamantha C Burnham, Christopher C Rowe, David Baker, et al.
Communications Medicine|February 27, 2025
Alzheimer's disease biological PET staging using plasma p217+tauAzadeh Feizpour, Vincent Doré, Natasha Krishnadas, et al.
Alzheimer'S Research & Therapy|April 11, 2015
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohortVeer B Gupta, Andrea C Wilson, Samantha Burnham, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's diseaseKunal Dhiman, Veer Bala Gupta, Victor L Villemagne, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2005
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathwayRoberto Cappai, Su-Ling Leck, Deborah J Tew, et al.
Nature|February 9, 2018
High performance plasma amyloid-β biomarkers for Alzheimer's diseaseAkinori Nakamura, Naoki Kaneko, Victor L Villemagne, et al.
Pageof 78